Kernel Cox partially linear regression: building predictive models for cancer patients' survival
Yaohua Rong, Sihai Dave Zhao, Xia Zheng, Yi Li

TL;DR
This paper introduces a novel regularized kernel Cox model with a LASSO penalty for predicting cancer patient survival, effectively handling high-dimensional molecular data and irrelevant predictors.
Contribution
It develops a semi-parametric kernel Cox model with a new regularized kernel machine method that improves prediction accuracy and feature selection in high-dimensional survival analysis.
Findings
Proposed method outperforms existing models in simulation studies.
Successfully applied to multiple myeloma data to classify patient risk.
Enhances survival prediction accuracy using gene expression data.
Abstract
Wide heterogeneity exists in cancer patients' survival, ranging from a few months to several decades. To accurately predict clinical outcomes, it is vital to build an accurate predictive model that relates patients' molecular profiles with patients' survival. With complex relationships between survival and high-dimensional molecular predictors, it is challenging to conduct non-parametric modeling and irrelevant predictors removing simultaneously. In this paper, we build a kernel Cox proportional hazards semi-parametric model and propose a novel regularized garrotized kernel machine (RegGKM) method to fit the model. We use the kernel machine method to describe the complex relationship between survival and predictors, while automatically removing irrelevant parametric and non-parametric predictors through a LASSO penalty. An efficient high-dimensional algorithm is developed for the…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsComputational Drug Discovery Methods · Statistical Methods in Clinical Trials · Gene expression and cancer classification
